Norges Bank Revolution Medicines, Inc. Transaction History

Norges Bank

  • $736 Billion
  • Q4 2024

A detailed history of Norges Bank transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Norges Bank holds 1,742,039 shares of RVMD stock, worth $72 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,742,039
Holding current value
$72 Million
% of portfolio
0.01%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$42.97 - $60.6 $74.9 Million - $106 Million
1,742,039 New
1,742,039 $76.2 Million
Q2 2024

Aug 14, 2024
BUY
$30.14 - $40.68 $55.7 Million - $75.2 Million
1,848,647 New
1,848,647 $71.7 Million
Q4 2023

Feb 09, 2024
BUY
$18.35 - $34.12 $5.17 Million - $9.61 Million
281,705 New
281,705 $8.08 Million
Q3 2023

Nov 13, 2024
BUY
$25.17 - $35.05 $11.1 Million - $15.4 Million
439,687 New
439,687 $12.2 Million
Q3 2023

Nov 13, 2023
SELL
$25.17 - $35.05 $14 Million - $19.4 Million
-554,741 Closed
0 $0
Q2 2023

Aug 14, 2024
SELL
$20.28 - $27.0 $30 Million - $40 Million
-1,481,160 Reduced 80.12%
367,487 $9.83 Million
Q2 2023

Aug 14, 2023
SELL
$20.28 - $27.0 $9.98 Million - $13.3 Million
-492,007 Closed
0 $0
Q1 2023

May 15, 2024
BUY
$20.76 - $30.09 $10.7 Million - $15.5 Million
514,016 New
514,016 $11.1 Million
Q4 2022

Feb 14, 2023
BUY
$17.68 - $25.53 $11 Million - $15.9 Million
622,641 New
622,641 $14.8 Million
Q3 2022

Nov 13, 2023
BUY
$17.46 - $26.0 $9.69 Million - $14.4 Million
554,741 New
554,741 $10.9 Million
Q2 2022

Aug 14, 2023
BUY
$14.54 - $27.17 $7.15 Million - $13.4 Million
492,007 New
492,007 $9.59 Million
Q1 2022

May 12, 2023
SELL
$17.31 - $26.4 $2.6 Million - $3.96 Million
-150,090 Reduced 24.11%
472,551 $12.1 Million
Q1 2022

May 09, 2022
SELL
$17.31 - $26.4 $7.95 Million - $12.1 Million
-459,043 Closed
0 $0
Q4 2021

Mar 09, 2022
BUY
$24.35 - $33.7 $11.2 Million - $15.5 Million
459,043 New
459,043 $11.6 Million
Q3 2021

Nov 14, 2022
BUY
$23.95 - $33.41 $9.72 Million - $13.6 Million
405,966 New
405,966 $11.2 Million
Q3 2021

Nov 05, 2021
SELL
$23.95 - $33.41 $2.07 Million - $2.89 Million
-86,566 Closed
0 $0
Q2 2021

Aug 15, 2022
BUY
$29.0 - $47.44 $2.51 Million - $4.11 Million
86,566 New
86,566 $2.75 Million
Q2 2021

Aug 10, 2021
SELL
$29.0 - $47.44 $4.89 Million - $8 Million
-168,734 Closed
0 $0
Q1 2021

May 09, 2022
BUY
$37.21 - $54.43 $6.28 Million - $9.18 Million
168,734 New
168,734 $7.74 Million
Q3 2020

Nov 10, 2020
SELL
$22.61 - $34.8 $1.09 Million - $1.68 Million
-48,245 Closed
0 $0
Q2 2020

Aug 13, 2021
BUY
$19.65 - $39.34 $948,014 - $1.9 Million
48,245 New
48,245 $1.52 Million
Q2 2020

Aug 07, 2020
SELL
$19.65 - $39.34 $1.38 Million - $2.75 Million
-70,000 Closed
0 $0
Q1 2020

May 07, 2021
BUY
$20.0 - $34.08 $1.4 Million - $2.39 Million
70,000 New
70,000 $1.53 Million

Others Institutions Holding RVMD

# of Institutions
299
Shares Held
179M
Call Options Held
920K
Put Options Held
1.06M
View Full List

About Revolution Medicines, Inc.

RVMD Quotes by TradingView
  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $3.63B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email